Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06035549 · ClinicalTrials.gov registry record
Resilience in East Asian Immigrants for Advance Care Planning Discussions
A clinical trial of Neoplasms and Advance Care Planning, sponsored by University of Illinois at Chicago.
- Recruiting
- Registry status
- 84
- Enrollment target
- 1
- Study location
NCT06035549 is a study of Neoplasms and Advance Care Planning that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 84 participants, below the 1,621-participant average among 158 other Neoplasms trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06035549, a study of Neoplasms and Advance Care Planning, is actively recruiting participants, sponsored by University of Illinois at Chicago.
- RECRUITING
- Registry status
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to develop a culturally tailored digital resilience-building intervention to help East Asian immigrants engage in advance care planning discussions with their family caregivers.
Conditions Studied
Interventions
- BEHAVIORAL Culturally Tailored Digital Resilience-Building
- BEHAVIORAL Semi-structured interviews
Study Locations (1)
Illinois
- University of Illinois Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2023-10-27 |
| Est. Completion | 2026-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06035549
The ClinicalTrials.gov registry entry for NCT06035549 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,621-participant average among 158 other Neoplasms trials with a reported enrollment target (95% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Neoplasms appearing as the primary indexed condition, and to 2 interventions - of which Culturally Tailored Digital Resilience-Building is the first listed.
NCT06035549 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT06035549 about?
NCT06035549 is a clinical study titled "Resilience in East Asian Immigrants for Advance Care Planning Discussions". The purpose of the study is to develop a culturally tailored digital resilience-building intervention to help East Asian immigrants engage in advance care planning discussions with their family caregivers.
What is the current status of trial NCT06035549?
This trial is currently recruiting. The enrollment target is 84 participants. The study started on 2023-10-27. Estimated completion is 2026-06-30.
What conditions does trial NCT06035549 study?
This clinical trial studies the following conditions: Neoplasms, Advance Care Planning.
What interventions are being tested in trial NCT06035549?
The interventions under investigation include: Culturally Tailored Digital Resilience-Building (BEHAVIORAL), Semi-structured interviews (BEHAVIORAL).
Who is sponsoring clinical trial NCT06035549?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06035549 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
RECRUITING · Phase 1
-
Real World Registry for Use of the Ion Endoluminal System
RECRUITING
-
A Study of GSK5764227 in Participants With. Advanced Solid Tumors (EMBOLD PanTumor-101)
RECRUITING · Phase 1
-
Endometrial Cell Collection With the PadKit
RECRUITING · NA
-
Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
RECRUITING · Phase 1
-
Serious Gaming for Chemotherapy-induced Nausea and Vomiting
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.